KDM1A and neoplasm: In addition, combined treatment with a HOTAIR-EZH2 disrupting agent and an LSD1 inhibitor resulted in more profound tumor inhibition in vivo compared to either treatment alone through derepression of PUMA and p21 expression (Fig. 6C) (150).